Printer Friendly
The Free Library
14,560,361 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Chugai Pharmaceutical to Spin off Production Operations.


Tokyo, Japan, Jan 23, 2006 - (JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
) - Chugai Pharmaceutical announced on January 20 that it has decided to spin off its production operations currently conducted by its four plants in Ustunomiya, Ukima, Kamakura and Fujieda.

Specifically, the company's subsidiary Chugai Techno techno

electronic dance music that first appeared in the U.S. in the 1980s and became globally popular in the 1990s. It originated with Detroit deejay-producers who, inspired by European electro-pop, underlaid dreamy synthesizer melodies with rapid electronic rhythms.
 Business will take over the relevant operations as of May 1. In addition, Chugai Techno Business will rename Re`name´   

v. t. 1. To give a new name to.

Verb 1. rename - assign a new name to; "Many streets in the former East Germany were renamed in 1990"
 itself to Chugai Pharma Manufacturing Co., Ltd. as of April 1.

With this move, Chugai Pharmaceutical aims to streamline its production operations in line with its mid-term business plan "Sunrise Sunrise, city (1990 pop. 64,407), Broward co., SE Fla., a residential suburb 8 mi (13 km) W of Fort Lauderdale; inc. 1961 as Sunrise Golf Village. It is a major office and commercial center and the site of Sawgrass Mills, one of the largest malls in the United States.  2010" while strengthening its proprietary technologies and improving cost performance.

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Jan 26, 2006
Words:108
Previous Article:HABA to Market New Supplement in February.
Next Article:Oki Electric to Launch Outpatient Paging System Using PHS-based Message Card.



Related Articles
Chugai Pharmaceutical Discloses Clinical Trial Information through JAPIC Website.
National Institute of Technology and Evaluation, Astellas Pharma, Chugai Pharmaceutical to Collaborate in Searching Microorganisms in Vietnam.
Chugai Pharmaceutical Now Features Disease Information Website in Japanese.
Chugai Pharmaceutical Renovates Its Website for Actemra, Drug for the Castleman's Disease.
Tokyo District Court Dismisses Ajinomoto's Patent Infringement Case against Chugai Pharmaceutical.
Chugai Files NDA for an Anti-Tumor Agent, Erlotinib (Epidermal Growth Factor Receptor (EGFR/HER1) Tyrosine Kinase Inhibitor).
Chugai Announces Co-Development and Co-Marketing Agreement with Taisho Pharmaceutical for the Antiresorptive Bisphosphonate R484.
Chugai to Launch HIV Protease Inhibitor INVIRASE(R) Tablet 500mg on September 15.
Chugai Pharmaceutical to Establish an Oncology Unit.
Anti-Cancer Agent Avastin(R) Approved in Japan.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles